Učitavanje...
Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Chimeric antigen receptor (CAR) is a recombinant immunoreceptor combining an antibody-derived targeting fragment with signaling domains capable of activating cells, which endows T cells with the ability to recognize tumor-associated surface antigens independent of the expression of major histocompat...
Spremljeno u:
| Izdano u: | Protein Cell |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Higher Education Press
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5712290/ https://ncbi.nlm.nih.gov/pubmed/28466386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13238-017-0400-z |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|